rs3809578
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The ENST00000558445.6(TRPM1):c.55-25350C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.367 in 152,090 control chromosomes in the GnomAD database, including 10,992 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.37 ( 10992 hom., cov: 33)
Consequence
TRPM1
ENST00000558445.6 intron
ENST00000558445.6 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -2.06
Publications
3 publications found
Genes affected
TRPM1 (HGNC:7146): (transient receptor potential cation channel subfamily M member 1) This gene encodes a member of the transient receptor potential melastatin subfamily of transient receptor potential ion channels. The encoded protein is a calcium permeable cation channel that is expressed in melanocytes and may play a role in melanin synthesis. Specific mutations in this gene are the cause autosomal recessive complete congenital stationary night blindness-1C. The expression of this protein is inversely correlated with melanoma aggressiveness and as such it is used as a prognostic marker for melanoma metastasis. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Oct 2011]
TRPM1 Gene-Disease associations (from GenCC):
- congenital stationary night blindness 1CInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
- TRPM1-related retinopathyInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- congenital stationary night blindnessInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.96).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.775 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.367 AC: 55847AN: 151972Hom.: 10999 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
55847
AN:
151972
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.367 AC: 55855AN: 152090Hom.: 10992 Cov.: 33 AF XY: 0.372 AC XY: 27675AN XY: 74344 show subpopulations
GnomAD4 genome
AF:
AC:
55855
AN:
152090
Hom.:
Cov.:
33
AF XY:
AC XY:
27675
AN XY:
74344
show subpopulations
African (AFR)
AF:
AC:
11125
AN:
41490
American (AMR)
AF:
AC:
6148
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
AC:
1334
AN:
3470
East Asian (EAS)
AF:
AC:
4104
AN:
5160
South Asian (SAS)
AF:
AC:
1750
AN:
4818
European-Finnish (FIN)
AF:
AC:
4484
AN:
10564
Middle Eastern (MID)
AF:
AC:
114
AN:
292
European-Non Finnish (NFE)
AF:
AC:
25692
AN:
67988
Other (OTH)
AF:
AC:
826
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1807
3614
5422
7229
9036
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
554
1108
1662
2216
2770
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1862
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.